ArticleHuman molecular genetics2020

Gene therapy for Alzheimer's disease targeting CD33 reduces amyloid beta accumulation and neuroinflammation.

Ana Griciuc et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.